Taysha Gene Therapies's chart data is dated 2026-10-09. There is no active technical signal. There are 1 published signal records.
Taysha Gene Therapies last closed at $4.49 (+1.35%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -10.9×. Its overall grade ranks 397 of 738 stocks in Healthcare.
About this company
Taysha Gene Therapies last closed at $4.49 (+1.35%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 397/738
Valuation grade B
Related stocks
- NovartisCompetitor
유전자치료제·희귀질환 치료제 개발 영역에서 경쟁
- Bluebird BioCompetitor
유전자치료제 및 희귀 유전질환 치료제 분야 경쟁사
- Sarepta TherapeuticsCompetitor
유전질환·유전자 기반 치료제 개발 경쟁
About Taysha Gene Therapies
- What technical signals does Taysha Gene Therapies (TSHA) have?
- Taysha Gene Therapies current technical signals: no active technical signal.
- Is Taysha Gene Therapies a cup-and-handle pattern?
- No. Taysha Gene Therapies has no valid Cup signal right now.
- What published figures are available for Taysha Gene Therapies?
- Market cap: $1.23B. Trailing 12 months PER: -10.9×. Latest quarter PBR: 4.22×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Taysha Gene Therapies, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.